Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance IFX Therapy

Quantum Blue® fCAL Citation:

Ferreiro-Iglesias, R. Barreiro-de Acosta M, Otero Santiago M, Lorenzo Gonzalez A, Alonso de la Peña C, Benitez Estevez AJ, Dominguez-Muñoz JE., Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance IFX Therapy. J Clin Gastroenterol. 2016 Feb;50(2):147-51. doi: 10.1097/MCG.0000000000000312.

Highlight from this Publication

“We found FC to be a very accurate marker to exclude relapse within the following 2 month after administration of Infliximab.”

Read Citation
Quantum Blue® fCAL Assays are for Research Use Only. Not for use in diagnostic procedures in the US.
Quantum Blue® fCAL: Health Canada License:83477